focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMulberry Group Regulatory News (MUL)

Share Price Information for Mulberry Group (MUL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 120.00
Bid: 110.00
Ask: 130.00
Change: 0.00 (0.00%)
Spread: 20.00 (18.182%)
Open: 120.00
High: 120.00
Low: 120.00
Prev. Close: 120.00
MUL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grants under Deferred Bonus Plan

6 Jul 2012 15:09

RNS Number : 1457H
Mulberry Group PLC
06 July 2012
 



Mulberry Group plc

 

Grants under Deferred Bonus Plan, Issue of new Ordinary Shares and Transfer of Shares

 

Grants under Deferred Bonus Plan and Issue of new Ordinary Shares

 

On 1 July 2012 Mulberry Group plc ("Mulberry" or "the Company") granted awards of deferred ordinary shares of 5 pence each in the Company ("Ordinary Shares") under Mulberry's Deferred Bonus Plan at a price of 1,475.5 pence per Ordinary Share. These grants relate to bonus payments awarded to the Executive Directors and other key employees in respect of the Company's performance for the financial year ended 31 March 2012. The deferred Ordinary Shares, which are held within the Mulberry Group plc Employee Benefit Trust ("the Trust"), will vest on 1 July 2014.

 

The total number of Ordinary Shares subject to these grants is as follows:

 

Name

Number of deferred Ordinary Shares granted under Deferred Bonus Plan

Roger Mather

3,253

Other key employees

21,862

Total

25,115

 

In addition to the grant of deferred Ordinary Shares under the deferred Bonus Plan, a matching number of nil cost options have been awarded. The options in this grant will vest on 1 July 2014 and are exercisable between 1 July 2014 and 1 July 2022.

 

Name

Number of matching nil cost options granted

Roger Mather

3,253

Other key employees

21,862

Total

25,115

 

In order to ensure that the Trust has sufficient shares to cover the awards of deferred Ordinary Shares, the Company has approved the issue of 20,000 new Ordinary Shares to the Trust.

 

Application has been made to the London Stock Exchange for the new Ordinary Shares to be admitted to AIM and it is expected that admission will take place on 12 July 2012.

 

Transfer of shares

 

Following vesting of earlier deferred interests under Mulberry's Deferred Bonus Plan, a number of Ordinary Shares have been transferred from the Trust to certain Directors as follows:

 

Name

Number of Ordinary Shares transferred from the Trust

Roger Mather

19,768

Godfrey Davis

24,330

 

Following these transactions;

 

Roger Mather's beneficial interest in the Company consists of 32,166 Ordinary Shares representing 0.05% of the Company's issued Ordinary Shares. Roger Mather also holds rights over 250,000 Ordinary Shares under Mulberry's Co-Ownership Plan, 10,449 unvested deferred Ordinary Shares, 10,449 unvested matching nil cost options and 19,768 vested nil cost options all under the Company's Deferred Bonus Plan.

 

Godfrey Davis' beneficial interest in the Company consists of 713,490 Ordinary Shares representing 1.20% of the Company's issued Ordinary Shares. Godfrey Davis also holds rights over 300,000 Ordinary Shares under Mulberry's Co-Ownership Plan, 5,037 unvested deferred Ordinary Shares, 5,037 unvested matching nil cost options, 24,330 vested nil cost options all under the Company's Deferred Bonus Plan and 90,000 options under the Company's 2008 Unapproved Share Option Scheme.

 

Total Voting Rights

 

The issued share capital of the Company following admission of the new Ordinary Shares will be 59,655,175 Ordinary Shares with a nominal value of 5 pence each. No Ordinary Shares are held in treasury. Therefore, the total number of voting rights in Mulberry is 59,655,175.

 

The figure of 59,655,175 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

 

Enquiries:

 

Pelham Bell Pottinger

Dan de Belder / Julia Hanrahan

0207 861 3232

Altium

Ben Thorne / Katherine Hobbs

0207 484 4040

Barclays Capital

Jon Bathard-Smith / Nicola Tennent

0203 134 9803

Mulberry Investor Relations

Amelia Fincher

0207 605 6771

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCRFMJTMBAMBJT
Date   Source Headline
12th Nov 20204:41 pmRNSSecond Price Monitoring Extn
12th Nov 20204:36 pmRNSPrice Monitoring Extension
5th Nov 20204:41 pmRNSSecond Price Monitoring Extn
5th Nov 20204:36 pmRNSPrice Monitoring Extension
3rd Nov 20204:34 pmRNSNotification of major holdings
3rd Nov 20204:21 pmRNSNotification of major holdings
16th Oct 20203:52 pmRNSAnnual Report and notice of General Meeting
6th Oct 20204:41 pmRNSSecond Price Monitoring Extn
6th Oct 20204:36 pmRNSPrice Monitoring Extension
5th Oct 20207:00 amRNSPreliminary Results
29th Sep 20204:41 pmRNSSecond Price Monitoring Extn
29th Sep 20204:35 pmRNSPrice Monitoring Extension
29th Sep 20207:00 amRNSUpdate on FY20 results
28th Sep 202012:15 pmRNSResult of AGM
17th Sep 20205:20 pmRNSNotification of Major Holdings
2nd Sep 20207:00 amRNSNotice of AGM
4th Aug 20204:41 pmRNSSecond Price Monitoring Extn
4th Aug 20204:36 pmRNSPrice Monitoring Extension
31st Jul 20204:41 pmRNSSecond Price Monitoring Extn
31st Jul 20204:36 pmRNSPrice Monitoring Extension
8th Jun 20209:15 amRNSCOVID-19 update and expected date of FY20 results
26th Mar 20204:41 pmRNSSecond Price Monitoring Extn
26th Mar 20204:35 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNSUpdate on trading and impact of COVID-19
23rd Mar 20207:00 amRNSDirector Dealing
20th Mar 20204:44 pmRNSSecond Price Monitoring Extn
20th Mar 20204:38 pmRNSPrice Monitoring Extension
17th Mar 20208:30 amRNSJohnny Coca to leave Mulberry
7th Feb 20209:34 amRNSHolding(s) in Company
6th Feb 20209:03 amRNSHolding(s) in Company
3rd Feb 20205:33 pmRNSHolding(s) in Company
3rd Feb 20205:30 pmRNSHolding(s) in Company
3rd Feb 20203:09 pmRNSHolding(s) in Company
26th Nov 20197:00 amRNSGrant of Options
13th Nov 20197:00 amRNSInterim Results
18th Sep 20197:00 amRNSAGM Statement
2nd Sep 20197:00 amRNSTotal Voting Rights
23rd Aug 20194:28 pmRNSIssue of Equity
22nd Aug 20197:00 amRNSAppointment of Group Finance Director
26th Jul 20197:00 amRNSAcquisition of minority interest
17th Jul 20193:59 pmRNSPosting of Annual Report
19th Jun 20197:00 amRNSPreliminary Results
19th Mar 20197:00 amRNSDirectorate Change
31st Dec 20187:00 amRNSTotal Voting Rights
4th Dec 20185:15 pmRNSIssue of Equity
7th Nov 20187:00 amRNSResults for the six months ended 30 September 2018
12th Oct 20184:35 pmRNSPrice Monitoring Extension
11th Oct 20184:40 pmRNSSecond Price Monitoring Extn
11th Oct 20184:35 pmRNSPrice Monitoring Extension
11th Sep 20181:59 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.